Division News and Events - Molecular Pharmaceutics and Drug Delivery

What Starts Here Changes the World

The Molecular Pharmaceutics and Drug Delivery faculty and labs are on the forefront of research in the field.  Our breakthroughs are regularly featured in the media and in academic publications. 

The Drug Dynamics Institute is now the Innovating for Health (i4Health) Institute

The Innovating for Health (i4Health) Institute has launched at the University of Texas at Austin, shifting the focus of the former Drug Dynamics Institute within the College of Pharmacy. The institute exists to foster collaborative innovation both on campus, with individuals, and with organizations across the globe. Learn more at i4health.info.

Announcements and Accomplishments

Kimmunity Lab Wins Its First Research Award

Molecular Pharmaceutics and Drug Delivery assistant professor B.J. Kim, Ph.D., has been selected as a 2025 Peg’s Fight for Life Early Career Research Award recipient from A Breath of Hope Lung Cancer Foundation. This award marks the first official research funding for the Kimmunity Lab. The prestigious award supports early-career investigators pursuing innovative research in lung cancer. Learn more in Dr. Kim's blog post.

Dr. Maria Croyle is Featured in Texas Monthly

Molecular Pharmaceutics and Drug Delivery Professor Maria A. Croyle, Ph.D. received extensive coverage in the March 2021 edition of Texas Monthly regarding her innovative peelable film drug delivery research. Among its many potential applications, Dr. Croyle’s technology could deliver COVID-19 vaccines through a small oral strip, without need for refrigeration or extensive storage and transportation infrastructure.

Dr. Maria Croyle Earns Funding for SARS-CoV-2 Research

Molecular Pharmaceutics and Drug Delivery professor Maria A. Croyle, Ph.D. earned 2021’s David Lehr Research Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Dr. Croyle will receive research funding to investigate novel regulatory mechanisms of drug metabolism in the context of active infection with SARS-CoV-2 and after recovery.

Division News

Dr. B.J. Kim's Kimmunity Lab Wins First Major Award to Develop RNA Therapies for EGFR-Mutant Lung Cancer

A banner headshot of Dr. B.J. Kim.
Nov. 21, 2025
B.J. Kim, Ph.D., and the Kimmunity Lab have received their first research award: the 2025 Peg's Fight for Life Early Career Research Award from the A Breath of Hope Lung Cancer Foundation. Their funded project develops programmable RNA therapies to tackle immune resistance in EGFR-mutant non–small cell lung cancer, aiming to convert "cold" tumors into ones that respond to treatment. With this support, they'll drive forward their RNA immunotherapy platform, expand their team and build new collaborations.

Texas Pharmacy's Cui Among UT Faculty Awarded TRC4 Grants for Groundbreaking Trauma Research

A patient lies on a table in a busy operating room filled with machinery while doctors, nurses and medical staff attend to the patient.
Oct. 27, 2025
Zhengrong Cui, Ph.D., Professor of Molecular Pharmaceutics and Drug Delivery and Alfred and Dorothy Mannino Fellow in Pharmacy, is among the UT faculty awarded TRC4 grants. His project focuses on developing dry powders of whole blood to improve storage and transport for trauma care. This innovative approach could expand access to life-saving transfusions in emergency situations.

Summer Research Fellowship Spotlight: Molly Levine

A woman standing in front of a pharmacy sign and giving the Hook 'em Horns hand gesture.
April 17, 2025
This month we highlight second-year student pharmacist Molly Levine and her research as part of the College of Pharmacy's Pharm.D. Honors Research Program.

New Faculty Spotlight

Dr. Qian Zhong Joins College of Pharmacy as Assistant Professor
We'd like to introduce and welcome Dr. Qian Zhong to the Division of Molecular Pharmaceutics and Drug Delivery faculty.  Dr. Zhong’s research integrates interdisciplinary approaches to engineer highly modular biomaterials-centric molecular probes and drug delivery systems to enable early detection of cancer and precision drug delivery of biologics. Most notably, Qian has developed a technology that utilizes only a nebulizer and a simple urine test to reveal early-stage lung cancer within 20 minutes.  You can read about this technology here.
 
You can contact Dr. Zhong at qian.zhong@austin.utexas.edu.
Dr. B.J. Kim Joins College of Pharmacy as Assistant Professor

Dr. Kim brings a wealth of expertise in RNA-based therapeutics, immunoengineering, and drug delivery, with a focus on developing innovative strategies for cancer treatment and vaccine design.

Dr. Kim earned her Ph.D. in Materials Science and Engineering from the University of California San Diego, where she specialized in RNA delivery under the mentorship of Professor Michael J. Sailor. She then pursued postdoctoral training at the Massachusetts Institute of Technology (MIT) with Professor Darrell J. Irvine, where she tackled immunological barriers to RNA vaccines and developed next-generation RNA delivery systems for infectious diseases and cancer immunotherapy.

At UT Austin, Dr. Kim is launching the Kimmunity Lab, which will integrate materials science, bioengineering, and immunology to advance RNA-based therapeutics and precision drug delivery technologies. Her research aims to optimize RNA formulations for cancer immunotherapy and vaccine development, leveraging high-throughput screening, immunoengineering, and machine learning to accelerate clinical translation.

Dr. Kim is excited to collaborate with researchers across disciplines and contribute to the college’s mission of advancing pharmaceutical innovation. To learn more about her work, visit the Kimmunity Lab website at kimmunotherapy.com.

Upcoming Events

Date and Time - End
Date and Time - End
Date and Time - End
No events at this time.